Article
Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy.
Cancer chemotherapy and pharmacology - 1 Nov 2021
Duran Goretti, Cruz Raquel, Aguín Santiago, Barros Francisco, Giráldez José María, Bernárdez Beatriz, Zarra Irene, López-López Rafael, Carracedo Ángel, Lamas María Jesús
Abstract excerpt
PURPOSE: Genetic variants in genes involved in the distribution, metabolism, accumulation or repair of lesions are likely to influence the response of drugs used in the treatment of Head and Neck Cancer (HNC). We examine the effect of 36 SNPs on clinical outcomes in patients with locally advanced HNC who were receiving platinum-based chemoradiotherapy (CRT). METHODS: These SNPs were genotyped in 110 patients...
Topics
- Adult
- Aged
- Aged, 80 and over
- Chemoradiotherapy
- Female
- Gene Frequency
- Haplotypes
- Head and Neck Neoplasms
- Humans
- Male
